Shufa Li

1.1k total citations
41 papers, 841 citations indexed

About

Shufa Li is a scholar working on Molecular Biology, Immunology and Plant Science. According to data from OpenAlex, Shufa Li has authored 41 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Immunology and 9 papers in Plant Science. Recurrent topics in Shufa Li's work include Plant biochemistry and biosynthesis (7 papers), Diabetes and associated disorders (6 papers) and Immune Cell Function and Interaction (6 papers). Shufa Li is often cited by papers focused on Plant biochemistry and biosynthesis (7 papers), Diabetes and associated disorders (6 papers) and Immune Cell Function and Interaction (6 papers). Shufa Li collaborates with scholars based in China and Macao. Shufa Li's co-authors include Debin Lu, Youzhao Jiang, Bing Chen, Wuquan Deng, Qinan Wu, Ziwen Liang, Zhonghui Zhang, Bing Xie, Sihao Chen and Jing Xu and has published in prestigious journals such as Diabetes, Diabetologia and Journal of Ethnopharmacology.

In The Last Decade

Shufa Li

38 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shufa Li China 13 372 234 207 164 160 41 841
Surjya Narayan Dash India 14 255 0.7× 186 0.8× 135 0.7× 172 1.0× 134 0.8× 23 821
Carola U. Niesler South Africa 21 666 1.8× 154 0.7× 206 1.0× 153 0.9× 147 0.9× 45 1.4k
Hongrun Yu United States 23 445 1.2× 88 0.4× 117 0.6× 33 0.2× 127 0.8× 41 1.3k
Victor R. Prisk United States 9 349 0.9× 115 0.5× 245 1.2× 115 0.7× 40 0.3× 13 764
Michael Coleman United States 21 936 2.5× 269 1.1× 351 1.7× 81 0.5× 368 2.3× 40 1.7k
Jenny M. Oldham New Zealand 17 595 1.6× 74 0.3× 75 0.4× 39 0.2× 175 1.1× 37 945
S. Goldstein United States 16 468 1.3× 239 1.0× 236 1.1× 38 0.2× 232 1.4× 28 1.3k
Roberto Bassi Italy 14 197 0.5× 71 0.3× 259 1.3× 31 0.2× 168 1.1× 20 686
Marcio Alvarez‐Silva Brazil 18 387 1.0× 182 0.8× 91 0.4× 9 0.1× 126 0.8× 38 983
Honghui He China 14 194 0.5× 84 0.4× 81 0.4× 81 0.5× 80 0.5× 32 491

Countries citing papers authored by Shufa Li

Since Specialization
Citations

This map shows the geographic impact of Shufa Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufa Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufa Li more than expected).

Fields of papers citing papers by Shufa Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shufa Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufa Li. The network helps show where Shufa Li may publish in the future.

Co-authorship network of co-authors of Shufa Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shufa Li. A scholar is included among the top collaborators of Shufa Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufa Li. Shufa Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chengqian, et al.. (2025). Finerenone in Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Efficacy and Safety. Diabetes/Metabolism Research and Reviews. 41(6). e70075–e70075.
2.
Guo, Mengqi, Han Guo, Chuan Wan, et al.. (2024). A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes. Diabetologia. 67(4). 623–640. 7 indexed citations
3.
Zhou, Chi, Fuhai Li, Wenzhong Zhang, et al.. (2024). TFPI2 hypermethylation promotes diabetic atherosclerosis progression through the Ap2α/PPARγ axis. Journal of Molecular and Cellular Cardiology. 198. 45–59. 5 indexed citations
4.
Dong, Bingzi, Jingjing Zhu, Xian Chen, et al.. (2023). The Emerging Role of Interleukin-(IL)-11/IL-11R in Bone Metabolism and Homeostasis: From Cytokine to Osteokine. Aging and Disease. 14(6). 2113–2113. 10 indexed citations
5.
Li, Shufa, et al.. (2022). Type 1 Diabetes Mellitus‐Related circRNAs Regulate CD4+ T Cell Functions. BioMed Research International. 2022(1). 4625183–4625183. 5 indexed citations
6.
Li, Shufa, et al.. (2019). Effects of shading on photosynthesis and anatomical structure in leaves of Rhododendron.. 39(6). 802–811. 1 indexed citations
7.
Sun, Hong, et al.. (2018). Gene silencing of ZnT8 attenuates inflammation and protects pancreatic tissue injury in T1D. Immunology Letters. 198. 1–6. 6 indexed citations
8.
Huang, Qiujing, et al.. (2018). miR-330-5p/Tim-3 axis regulates macrophage M2 polarization and insulin resistance in diabetes mice. Molecular Immunology. 95. 107–113. 42 indexed citations
9.
Zhang, Min, et al.. (2018). Identification of HLA-A2-restricted immunogenic peptides derived from Vitamin D-Binding Protein. Cellular Immunology. 328. 18–23. 1 indexed citations
10.
Zhang, Min, et al.. (2016). ZnT8107-115/HLA-A2 dimers attenuate the severity of diabetes by inducing CD8+ T cell tolerance. Immunology Letters. 180. 66–72. 4 indexed citations
11.
Li, Shubin, Ningning Zhou, Huijun Yan, et al.. (2015). Inheritance of Perpetual Blooming in Rosa chinensis ‘Old Blush’. Horticultural Plant Journal. 1(2). 108–112. 18 indexed citations
12.
Meng, Ke, et al.. (2014). The Survey on Implementation of Evidence-Based Nursing in Preventing Ventilator-Associated Pneumonia and the Effect Observation. Cell Biochemistry and Biophysics. 71(1). 375–381. 5 indexed citations
13.
Li, Shufa. (2013). Studies on Phenotypic Diversity of Vulnerable Rosa praelucens Endemic to Shangrila,Yunnan. Acta Horticulturae Sinica. 6 indexed citations
14.
Li, Shufa, Haiying Li, Bing Chen, et al.. (2012). Identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from Zinc Transporter 8. Vaccine. 31(12). 1610–1615. 16 indexed citations
15.
Li, Shufa, et al.. (2011). Dendritic cells expressing BTLA induces CD8+ T cell tolerance and attenuates the severity of diabetes. Vaccine. 29(44). 7747–7751. 10 indexed citations
16.
Qiu, Xianqin, Hao Zhang, Hongying Jian, et al.. (2010). Phenotypic diversity of natural populations of Rosa brunonii Lindl. in Yunnan.. Yunnan Nongye Daxue xuebao. 25(2). 200–206. 1 indexed citations
17.
Zhang, Ting, Hongying Jian, Qigang Wang, et al.. (2010). Study on karyotype of eleven Chinese Old Garden Roses.. Xi'nan nongye xuebao. 23(5). 1656–1659. 1 indexed citations
18.
Li, Shufa, Jianyong Zhao, Jianping Liu, et al.. (2010). Prospective randomized controlled study of a Chinese herbal medicine compound Tangzu Yuyang Ointment for chronic diabetic foot ulcers: A preliminary report. Journal of Ethnopharmacology. 133(2). 543–550. 41 indexed citations
19.
Yan, Huijun, Hao Zhang, Shufa Li, et al.. (2009). Development of new SSR markers from EST of SSH cDNA libraries on rose fragrance. Hereditas (Beijing). 31(9). 962–966. 2 indexed citations
20.
Li, Shufa. (2005). Briefing on Promoting Cultivation of Pleione yunnanensis in Winter Time. Yunnan Nongye Daxue xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026